[1]
“The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy ”, Ann Med Res , vol. 26, no. 10, pp. 2098–2104, May 2021, Accessed: Apr. 03, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/1820